27 April, 2017
Update for pathology laboratories
Due to the complexity of assimilating and migrating data from eight state and territory cancer registers into one register, the start date for Australia’s first National Cancer Screening Register and the renewal of the National Cervical Screening Program is now 1 December 2017.
As we transition, laboratories will be notified when cervical screening test results are to be sent to the National Cancer Screening Register and when to cease sending results to the State and Territory registers. The Australian Department of Health and Telstra Health are working as one team to deliver the National Cancer Screening Register committed to delivering a high quality register to safely support the 11 million Australians participating in the cervical and bowel screening programs.
Connecting to the National Cancer Screening Register
Laboratories wishing to connect to the NCSR by go live date must apply by August 2017. The Provider Integration Guide is a technical document that will support your technical team in developing the National Cancer Screening Register interface.
Features of the National Cancer Screening Register for laboratories
- Provision of statistical data for calculating performance measures.
- Search function for authorised laboratory staff to manually search for patient screening histories where required and for quality assurance data
- A dedicated pathology contact will be the liaison for technical and transition queries in the transition to the new National Register.
Email (for all enquiries): NCSRpathology@team.telstra.com
17 February, 2017
The RCPA Board of Directors is proposing changes to the College Constitution to be considered by Fellows at the AGM later this year. The changes relate to the use of post-nominals, the ability of the College to discipline members and the ability of the College to notify regulatory authorities of issues relating to membership. Please follow this link to read a Communique from the President regarding the proposed changes. If you have queries or concerns regarding the communique, please contact Dr Debra Graves, CEO at email@example.com